Literature DB >> 21993564

Proteinase-activated receptors 1 and 2 regulate invasive behavior of human melanoma cells via activation of protein kinase D1.

Cordula Kempkes1, Anke Rattenholl, Jörg Buddenkotte, Elwira Strozyk, Jürgen Eberle, Angelika Hausser, Ferda Cevikbas, Stefan W Schneider, Martin Steinhoff.   

Abstract

Recent studies have indicated an important role of proteinases and proteinase-activated receptors (PARs) in tumorigenesis. Although a role for PARs has been described in various skin tumors including melanoma, the underlying cellular mechanisms have not been understood. Recent studies have suggested PAR(1) as a regulator of melanoma cell growth and metastasis by affecting angiogenic and invasive factors. Moreover, changes in the expression patterns of PAR(1) and PAR(2) correlate with skin cancer progression, and PAR(1) is overexpressed in melanoma. Therefore, we sought to elucidate the putative role of PAR(1)- and PAR(2)-mediated signal transduction pathways during melanoma progression. Activation of both PAR(1) and PAR(2) led to rapid phosphorylation of protein kinase D1 (PKD1) in cultured WM9 melanoma cells. PKD1 is known to be involved in cell migration, integrin regulation, and intracellular vesicle transport. Downregulation of PKD1 by siRNA resulted in diminished proliferation, decreased αvβ3 integrin regulation, and secretion of pro-angiogenic chemokine IL-8 in WM9 cells. In conclusion, our results show that PAR(1) and PAR(2) are involved in WM9 cell proliferation and secretion of IL-8 by activation of PKD1. Inactivation of the PKD1 pathway may be beneficial for the inhibition of PAR-induced melanoma proliferation and for maintenance of the inflammatory tumor environment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993564      PMCID: PMC3704140          DOI: 10.1038/jid.2011.314

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  51 in total

1.  Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin.

Authors:  S C Even-Ram; M Maoz; E Pokroy; R Reich; B Z Katz; P Gutwein; P Altevogt; R Bar-Shavit
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.

Authors:  M L Nierodzik; F Kajumo; S Karpatkin
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

3.  Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

Authors:  Jörg Buddenkotte; Christopher Stroh; Ingo H Engels; Corinna Moormann; Victoria M Shpacovitch; Stephan Seeliger; Nathalie Vergnolle; Dietmar Vestweber; Thomas A Luger; Klaus Schulze-Osthoff; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

4.  PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

Authors:  Adrienne Boire; Lidija Covic; Anika Agarwal; Suzanne Jacques; Sheida Sherifi; Athan Kuliopulos
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

5.  Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.

Authors:  Carmen Tellez; Marya McCarty; Maribelis Ruiz; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2003-09-15       Impact factor: 5.157

Review 6.  Role and regulation of the thrombin receptor (PAR-1) in human melanoma.

Authors:  Carmen Tellez; Menashe Bar-Eli
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

Review 7.  Alpha-v integrins as therapeutic targets in oncology.

Authors:  Jeffrey A Nemeth; Marian T Nakada; M Trikha; Zhihui Lang; Michael S Gordon; Gordon C Jayson; Robert Corringham; Uma Prabhakar; Hugh M Davis; Robert A Beckman
Journal:  Cancer Invest       Date:  2007-10       Impact factor: 2.176

8.  PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration.

Authors:  Tim Eiseler; Michael A Schmid; Fitnat Topbas; Klaus Pfizenmaier; Angelika Hausser
Journal:  FEBS Lett       Date:  2007-08-10       Impact factor: 4.124

9.  Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.

Authors:  Gabriel J Villares; Andrey S Dobroff; Hua Wang; Maya Zigler; Vladislava O Melnikova; Li Huang; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

10.  Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils.

Authors:  Victoria M Shpacovitch; Stephan Seeliger; Markus Huber-Lang; Sandra Balkow; Micha Feld; Morley D Hollenberg; Vidya J Sarma; Peter A Ward; Anke Strey; Volker Gerke; Christian P Sommerhoff; Nathalie Vergnolle; Martin Steinhoff
Journal:  Exp Dermatol       Date:  2007-10       Impact factor: 3.960

View more
  5 in total

1.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

2.  Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1.

Authors:  Messaouda Merzoug-Larabi; Caroline Spasojevic; Marianne Eymard; Caroline Hugonin; Christian Auclair; Manale Karam
Journal:  BMC Cancer       Date:  2017-01-05       Impact factor: 4.430

3.  PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

Authors:  Caroline Spasojevic; Elisabetta Marangoni; Sophie Vacher; Franck Assayag; Didier Meseure; Sophie Château-Joubert; Martine Humbert; Manale Karam; Jean Marc Ricort; Christian Auclair; Marie Regairaz; Ivan Bièche
Journal:  Oncotarget       Date:  2018-05-01

4.  Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells.

Authors:  Gavuthami Murugesan; Alan R Prescott; Rachel Toth; David G Campbell; Claire M Wells; Carol MacKintosh
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

5.  Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin.

Authors:  Barbara Hernando; Maider Ibarrola-Villava; Lara P Fernandez; Maria Peña-Chilet; Marta Llorca-Cardeñosa; Sara S Oltra; Santos Alonso; Maria Dolores Boyano; Conrado Martinez-Cadenas; Gloria Ribas
Journal:  Biol Sex Differ       Date:  2016-03-18       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.